Physical audiological principles of implantable hearing systems : About power transmission, coupling and power output.

[Physical audiological principles of implantable hearing systems : About power transmission, coupling and power output]. HNO. 2019 Nov 08;: Authors: Rahne T Abstract Implantable hearing systems work because mechanical vibration energy is introduced into the hearing system. The performance of the hearing system is thus essentially determined by physical parameters. Together with the tone and speech audiogram the indications for deciding on a system are based on the efficacy of the respective system and the patient's wishes. Hearing-assisted patients should have a dynamic range of 30-35 dB to adequately understand speech. This should be guaranteed with the respective system also in the medium to long term. In addition, sufficient cochlear reserve performance for implantable hearing systems is critical for success. The expected and achieved audiological success can be the effective gain as a difference of aided hearing threshold to bone conduction threshold and should be preferred to the unreflecting use of gain or functional gain. With good differential diagnostic indications and the inclusion of conventional hearing aids and cochlear implants, optimal hearing solutions can be found for almost all patients. PMID: 31705301 [PubMed - as supplied by publisher]
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research

Related Links:

This article aims to describe initiatives that have been implemented that promote physical activity. More family physicians have become interested in promoting physical activity in their clinical practice. Specific training has become more widely available, computer based tools have been developed as clinical practice aids (for evaluation of levels of physical activity and counselling) and local initiatives involving health professionals have increased, as well as more investment in terms of investigation and monitoring of all of the above. At the same time change is happening among urban spaces and local policies that fav...
Source: Ciencia e Saude Coletiva - Category: Occupational Health Source Type: research
Photo credit William Krause Dear Carol: My 93-year-old grandma has hearing aids, but she refuses to wear them. Her hearing without them is poor, and while she's taught herself to read lips, that only works if I'm standing right in front of her. My husband's so frustrated that he stood in front of her the other morning and said, “I am not going to talk to you until you put your hearing aids in your ears.” I understand his frustration, but his response doesn't seem right either. Could there be some logical reason why Grandma won't wear her hearing aids? — WS. Continue reading on Inforum to learn more a...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
Perinatal antiretroviral intensification may prevent intrapartum transmission of HIV in women who start combination antiretroviral therapy (cART) late in pregnancy, new research suggests.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Funding to enhance nursing education and strengthen the nursing workforce through experiential learning opportunities, including the use of simulation-based technology to improve the health of patients, families, and communities in rural and medically underserved areas experiencing diseases and conditions that affect public health. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - Category: Infectious Diseases Source Type: funding
Purpose of review The available vaccine and therapies against hepatitis B virus (HBV) rarely eliminate chronic infection with the virus. High mortality resulting from complicating cirrhosis and hepatocellular carcinoma makes improving anti-HBV therapy an important priority. Recent advances with using gene therapy to counter HBV have potential and are the focus of this review. Recent findings The stable replication-competent HBV intermediate comprising covalently closed circular DNA (cccDNA) is the template for expression of all viral genes. Inactivating cccDNA has thus been a focus of research aimed at achieving cure ...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
Purpose of review The cure for hepatitis C virus infection has raised hope for a potential hepatitis B virus (HBV) cure, but the high price tag has led to serious questions about the affordability, and thus to access for all. This review discusses cost-effectiveness models, affordability, and access to a potential new cure for chronic HBV infection. Recent findings A cure does not yet exist for HBV, but the antiviral treatments that are currently available help slow down the progression of disease. There is limited research in the area of cost-effectiveness and economic analysis comparing a potential cure. Our prelimi...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
No abstract available
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: EDITORIAL INTRODUCTIONS Source Type: research
No abstract available
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
Purpose of review The aim of this study was to identify similarities, differences and lessons to be shared from recent progress in HIV and hepatitis B virus (HBV) immunotherapeutic approaches. Recent findings Immune dysregulation is a hallmark of both HIV and HBV infection, which have shared routes of transmission, with approximately 10% of HIV-positive patients worldwide being coinfected with HBV. Immune modulation therapies to orchestrate effective innate and adaptive immune responses are currently being sought as potential strategies towards a functional cure in both HIV and HBV infection. These are based on activa...
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
This article is designed to summarize the HBV life cycle in order to review the current treatment strategies and compounds targeting different points of the virus life cycle, which are either in preclinical or clinical phases. Recent findings Recently our developed understanding of the HBV life cycle has enabled the development of multiple novel treatment options, all aiming for functional cure. Summary It is likely that combinations of novel treatments will be needed to achieve a functional cure, including those that target the virus itself as well as those that target the immune system.
Source: Current Opinion in HIV and AIDS - Category: Infectious Diseases Tags: HIV AND HEPATITIS B CURE: Edited by Sharon R. Lewin and Peter A. Revill Source Type: research
More News: Audiology | ENT & OMF | HIV AIDS